BenQ Medical Technology (4116) — Cash Flow Quality Index
BenQ Medical Technology (4116) has a Cash Flow Quality Index of 18.36x as of June 2025. Operating cash flow of NT$179.07 Million exceeds net income of NT$9.76 Million, indicating high earnings quality where cash backs reported profits. Also explore BenQ Medical Technology asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BenQ Medical Technology Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for BenQ Medical Technology across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BenQ Medical Technology (4116) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for BenQ Medical Technology (2017–2024)
Year-by-year earnings quality comparison for BenQ Medical Technology. For live market cap and the full company financial profile, see market value of BenQ Medical Technology.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.12x | NT$222.22 Million | NT$104.83 Million | ▼ -45.1% |
| 2023 | 3.86x | NT$442.35 Million | NT$114.58 Million | ▲ +83.7% |
| 2022 | 2.10x | NT$378.77 Million | NT$180.24 Million | ▲ +7.0% |
| 2021 | 1.96x | NT$121.35 Million | NT$61.78 Million | ▲ +37.0% |
| 2020 | 1.43x | NT$151.48 Million | NT$105.67 Million | ▲ +1.1% |
| 2019 | 1.42x | NT$169.23 Million | NT$119.30 Million | ▼ -25.0% |
| 2018 | 1.89x | NT$126.10 Million | NT$66.68 Million | ▲ +20.9% |
| 2017 | 1.56x | NT$72.97 Million | NT$46.63 Million | — |